跳至主要内容
临床试验/NCT01943240
NCT01943240撤回4 期

Improvement of Analgesia With Addition of Pectoral Nerve Block to Thoracic Paravertebral Blocks in Unilateral Total Simple Mastectomy

Timothy R Petersen1 个研究点 分布在 1 个国家开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
1
主要终点
Total opioid consumption in post anesthesia care unit (PACU)

研究概览

简要总结

Our routine practice for patients undergoing mastectomy is to include paravertebral peripheral nerve blockade for postoperative analgesia. This study investigates whether the addition of another nerve block targeting the pectoral nerves will improve that analgesia.

详细描述

Randomization:

20 patients will be randomized into 2 groups. Both groups will receive paravertebral blocks with 4 mL of 0.5% ropivacaine at each of six levels.

Group A: Active group with 10 cc of 0.375% ropivacaine (16) pectoral nerve block Group S: Placebo group with 10 cc of normal saline for pectoral nerve block

Blinding:

The injectate contents for the lateral pectoral nerve block will be blinded to all personnel involved in performing the block, all personnel involved in the general anesthesia and all personnel involved in assessing the patient for pain in the postoperative recovery period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years and older
  • Able to provide own consent
  • Simple mastectomy at University of New Mexico Hospital without planned axillary surgery

排除标准

  • Spinal deformity or pathology
  • Chest wall deformity or pathology
  • Bilateral simple mastectomy
  • Refusal of regional anesthesia
  • Chronic pain
  • History of recent drug or alcohol abuse
  • History of recent psychiatric problems
  • Allergies to lidocaine or ropivacaine
  • Allergies to fentanyl or hydromorphone
  • Surgery that extends beyond the original plan to include axillary exposure

研究组 & 干预措施

Group A

Experimental

Paravertebral peripheral nerve blockade with with 4 mL of 0.5% ropivacaine at each of six levels, plus 10 cc of 0.375% ropivacaine for pectoral nerve block

干预措施: 10 cc of 0.375% ropivacaine pectoral nerve block (Drug)

结局指标

主要结局

Total opioid consumption in post anesthesia care unit (PACU)

时间窗: Up to 8 hours

次要结局

  • Postoperative nausea and vomiting (PONV)(Up to 8 hours)
  • Maximum pain score in PACU (numerical rating scale)(Up to 8 hours)
  • Patient satisfaction with block(1 day)
  • Time to meet PACU discharge criteria(Up to 8 hours)

研究者

发起方
Timothy R Petersen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Timothy R Petersen

Research Information Specialist

University of New Mexico

研究点 (1)

Loading locations...

相似试验